ARTICLES BY RONALD A. RADER
-
![Shooting Rocket]( "Biosimilar Pipeline Experiencing 12% Annual Growth: A Progress Update")
Biosimilar Pipeline Experiencing 12% Annual Growth: A Progress UpdateThis article compares aspects of the biosimilar development pipeline and related market evolution since 2013, including what has and hasn’t changed.
-
![Tree-growth-increase-iStock-924834270]( "Biosimilars Pipeline Shows Remarkable, Sustained Growth")
Biosimilars Pipeline Shows Remarkable, Sustained GrowthThe biosimilars pipeline is progressing rapidly and continues to grow, with more products and more organizations involved. This article reviews the current biosimilars development pipeline and progress.
-
![2019-iStock-892736210]( "Top Trends In The Biopharmaceutical Industry And Bioprocessing For 2019")
Top Trends In The Biopharmaceutical Industry And Bioprocessing For 2019This article presents trends and findings from a survey and study of 222 responsible individuals at biopharmaceutical manufacturers and CMOs in 22 countries, as well as over 130 direct suppliers of materials, services, and equipment to this industry.
-
![biosimilar pipeline]( "Biosimilars Pipeline Analysis: Many Products, More Competition Coming")
Biosimilars Pipeline Analysis: Many Products, More Competition ComingOur discussion of biosimilars in this article will center on developed-market GMP biosimilars. In the European market alone, biosimilars already are a multibillion-dollar business, and one that is rapidly growing.
Ronald A. Rader
Ronald A. Rader is senior director, technical research, BioPlan Associates. He has 35+ years’ experience as a biotechnology and pharmaceutical, particularly biopharmaceutical, information specialist, analyst, and publisher. He has been responsible for publications/information resources including the Antiviral Agents Bulletin periodical, the Federal Bio-Technology Transfer Directory, BIOPHARMA: Biopharmaceutical Products in the U.S. and European Markets, and the Biosimilars/Biobetters Pipeline Directory. He can be contacted at info@bioplanassociates.com, 301-921-5979, and www.bioplanassociates.com.